Search Results for: stem cells for MS

‘We don’t want to freak people out’: about that Jacob Hanna human embryo model startup

/ / 5 Comments
Jacob Hanna Renewal Bio

Stem cell biologist Jacob Hanna has a new startup called Renewal Bio. Its goal is to harvest cells or tissues from human embryo or fetus models for clinical use. I believe that their commercial ambitions have so far outstripped careful thought and discussion in the broader community of researchers. There are major risks here for […]

‘We don’t want to freak people out’: about that Jacob Hanna human embryo model startup Read More »

Histone code series: H3K27me3 & H3K27ac functions & roles in diseases like DIPG

/ / 1 Comment
ASCL1 in K27M tumors, H3K27me3 loss

Histone proteins such as histone H3 are often popping up in science writing and news sometimes includes specific modified forms of H3 including one that we scientists call H3K27me3. What is in this article What is H3K27me3? | The histone code | H3K27ac and H3K27me3 function | H3K27 and human disease | References The goal of today’s post

Histone code series: H3K27me3 & H3K27ac functions & roles in diseases like DIPG Read More »

Weekly reads: fibroblasts, gene-editing, Mitalipov, personhood, embryos

/ / 1 Comment
NIH 3T3 fibroblasts ATCC

I have a soft spot for fibroblasts, perhaps because one of the first immortalized cell lines I ever grew was NIH3T3. These are mouse fibroblasts that have been immortalized. They are very useful for a variety of experiments. I used them to study an oncogene called E2A-PBX1. Experience with fibroblasts including 3T3s I was amazed

Weekly reads: fibroblasts, gene-editing, Mitalipov, personhood, embryos Read More »

Weekly reads: NIH grants, side effect of darker hair, FDA warning, CRISPR

/ / Leave a Comment
Grant writers handbook, grants cartoon

The last six months I’ve been spending even more time than usual writing NIH grants (and a few others). The last two weeks have been especially busy on this front as I am getting an R01 renewal out the door. My paper reading lately has been mostly related to the grant writing I’m doing. Still,

Weekly reads: NIH grants, side effect of darker hair, FDA warning, CRISPR Read More »

Weekly reads: teratoma in iPSC trial, Piero Anversa & friends, Athersys, China Initiative

/ / 1 Comment
Dr-Piero-Anversa

It’s been mostly a downbeat week on the stem cell news front including a deep revisit by Reuters to the Piero Anversa case that has new revelations. It’s ugly stuff involving other folks too. We’ll start on the iPS cell front, where a trial participant had a teratoma. I’ve had a long-standing interest in the

Weekly reads: teratoma in iPSC trial, Piero Anversa & friends, Athersys, China Initiative Read More »

Weekly reads: Jan Nolta recognition, new director after Irv, FDA guidance

/ / 2 Comments
Dr. Jan Nolta UC Davis

People are the real driving force in the stem cell and regenerative medicine field including my colleague Jan Nolta here at UC Davis. She is the Director of our Stem Cell Program. There’s also news about Stanford’s stem cell Director Irv Weissman. Jan Nolta receives award Jan’s lab is prolific and in many ways is

Weekly reads: Jan Nolta recognition, new director after Irv, FDA guidance Read More »

What are blastoids, roles in biomedical research, & ethical considerations

/ / 1 Comment
blastoids nature paper figure 2

Blastoids are lab-grown models of human embryos that represent a relatively new area of developmental biology research. The goal of today’s post is to give you everything you need to know about this topic. What’s in this article What are blastoids? | How are blastoids made? |  Use in research | Blastoids challenges & Ethics

What are blastoids, roles in biomedical research, & ethical considerations Read More »

Weekly reads: $1B Saudi anti-aging push, OCT4 necklace, cancer trial wows, coffee brain

/ / 1 Comment
Stem-Cells-Aging, anti-aging

I recently wrote about stem cell-related ideas for anti-aging and even cheating death, but there are of course other approaches including drugs like metformin. A new article outlines a massive research funding plan to tackle aging. Let’s start with that. Recommend reads including anti-aging Saudi Arabia plans to spend $1 billion a year discovering treatments to

Weekly reads: $1B Saudi anti-aging push, OCT4 necklace, cancer trial wows, coffee brain Read More »

One size doesn’t fit all? FDA may soften some cell therapy regs

/ / Leave a Comment
dr. peter marks fda, cell therapy

The Pink Sheet just broke the story that the FDA may change up its oversight of the cell therapy space. This possible shift could drop the oversight bar somewhat for certain products. Most likely it’d be those with lower anticipated risks. The Pink Sheet piece by Sue Sutter is titled US FDA To Explore New Regulatory Pathways

One size doesn’t fit all? FDA may soften some cell therapy regs Read More »

The Niche foreign language outreach program: 2.5 million reads

/ / Leave a Comment
stem cells

There was a time when The Niche was just about the only stem cell blog or even stem cell-dedicated website more generally across the globe. I realized early on that I needed to reach people who don’t speak English or for whom English is not their first language. This goal was crucial for effective educational

The Niche foreign language outreach program: 2.5 million reads Read More »